Panel Discussion: Weighing the Pros & Cons of Automated Manufacturing

• Exploring the adoption of automated manufacturing process to enhance consistency, output and decrease variability
• Examining integration and flexibility challenges in automation to inform realistic implementation strategies
• Analyzing the impact of automation on cost of goods to optimize resource allocation and support sustainable clinical and commercial manufacturing

Speakers:

Xiuyan Wang

Director - Cell Therapy & Cell Engineering Core

Memorial Sloan Kettering Cancer Center

Stephan Krause Stephan Krause

ED

Bristol Myers Squibb

Vaishali Shukla

Vice President, CGT & API Global Expansion

Eli Lilly & Co.

Nan Zhang

Cell Therapy Manufacturing Section, Center For Cellular Engineering, NIH Clinical Center Chief

National Institute of Health Science